Nick Brokhausen – MACV-SOG on Vietnam War, Hand-to-Hand Combat and a Crazy Pet Monkey | SRS #276October 22, 2026
Robert Jackson on October 22, 2026 9:17 pm Interesting update on Nick Brokhausen – MACV-SOG on Vietnam War, Hand-to-Hand Combat and a Crazy Pet Monkey | SRS #276. Curious how the grades will trend next quarter. Reply
Olivia Davis on October 22, 2026 9:18 pm Uranium names keep pushing higher—supply still tight into 2026. Reply
Michael Lopez on October 22, 2026 9:18 pm Exploration results look promising, but permitting will be the key risk. Reply
Robert Lee on October 22, 2026 9:19 pm The cost guidance is better than expected. If they deliver, the stock could rerate. Reply
Liam D. Thompson on October 22, 2026 9:22 pm The cost guidance is better than expected. If they deliver, the stock could rerate. Reply
Emma K. Jackson on October 22, 2026 9:23 pm Uranium names keep pushing higher—supply still tight into 2026. Reply
Emma Martin on October 22, 2026 9:25 pm I like the balance sheet here—less leverage than peers. Reply
Michael Williams on October 22, 2026 9:26 pm Uranium names keep pushing higher—supply still tight into 2026. Reply
Oliver O. Garcia on October 22, 2026 9:29 pm Nice to see insider buying—usually a good signal in this space. Reply
John Thompson on October 22, 2026 9:30 pm Silver leverage is strong here; beta cuts both ways though. Reply
21 Comments
Interesting update on Nick Brokhausen – MACV-SOG on Vietnam War, Hand-to-Hand Combat and a Crazy Pet Monkey | SRS #276. Curious how the grades will trend next quarter.
Uranium names keep pushing higher—supply still tight into 2026.
Good point. Watching costs and grades closely.
Good point. Watching costs and grades closely.
Exploration results look promising, but permitting will be the key risk.
The cost guidance is better than expected. If they deliver, the stock could rerate.
Good point. Watching costs and grades closely.
The cost guidance is better than expected. If they deliver, the stock could rerate.
Good point. Watching costs and grades closely.
Good point. Watching costs and grades closely.
Uranium names keep pushing higher—supply still tight into 2026.
I like the balance sheet here—less leverage than peers.
Good point. Watching costs and grades closely.
Good point. Watching costs and grades closely.
Uranium names keep pushing higher—supply still tight into 2026.
Good point. Watching costs and grades closely.
Good point. Watching costs and grades closely.
Nice to see insider buying—usually a good signal in this space.
Good point. Watching costs and grades closely.
Silver leverage is strong here; beta cuts both ways though.
Good point. Watching costs and grades closely.